Carriage frequency, intensity of carriage, and strains of oral yeast species vary in the progression to oral candidiasis in human immunodeficiency virus-positive individuals

Journal of Clinical Microbiology

Volumn 40, Issue 2, 2002, Pages 341-350

  Vargas, Kaaren G ^a   Joly, Sophie ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIAL COLONIZATION; CANDIDA; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; COMMENSALISM; CONTROLLED STUDY; FUNGAL STRAIN; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; THRUSH;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CANDIDA; CANDIDIASIS, ORAL; CARRIER STATE; CD4 LYMPHOCYTE COUNT; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED;

BACTERIA (MICROORGANISMS); CANDIDA; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; HUMAN IMMUNODEFICIENCY VIRUS; RNA VIRUSES;

EID: 0036164475     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.40.2.341-350.2002     Document Type: Article

References (51)

1. Characterization and partial nucleotide sequence of the DNA fingerprinting probe Ca3 of Candida albicans
2. Turbidimetric and visual criteria for determining the in vitro activity of six antifungal agents against Candida spp. and Cryptococcus neoformans
3. The secretion of aspartyl proteinase, a virulence enzyme, by isolates of Candida albicans from the oral cavity of HIV-infected subjects
4. The prevalence of oral candidiasis in HIV-infected individuals and dental attenders in Edinburgh
5. Asymptomatic oral Candida albicans carriage in HIV-infection: Frequency and predisposing factors
6. Asymptomatic oral carriage of Candida albicans in patients with HIV infection
7. Reduced azole susceptibility of oral isolates of Candida albicans from HIV-positive patients and a derivative exhibiting colony morphology variation
8. Susceptibility of oral bacteria and yeast to mammalian cathelicidins
9. Oral carriage of candida in healthy and HIV-seropositive persons
10. Fungal infections in patients with AIDS and AIDS-related complex
11. Hierarchical pattern of mucosal candida infections in HIV-seropositive women
12. Development and characterization of complex DNA fingerprinting probes for the infectious yeast Candida dubliniensis
13. Frequency, intensity, species, and strains of oral Candida vary as a function of host age
14. Clinical spectrum of oral candidosis and its role in HIV-infected patients
15. In vitro susceptibilities and biotypes of Candida albicans isolates from the oral cavities of patients infected with human immunodeficiency virus
16. An amino acid liquid synthetic medium for development of mycelial and yeast forms of Candida albicans
17. Molecular epidemiology of Candida albicans isolates from AIDS and cancer patients using a novel standardized CARE-2 DNA fingerprinting technique
18. Colonizing populations of Candida albicans are clonal in origin but undergo microevolution through C1 fragment reorganization as demonstrated by DNA fingerprinting and C1 sequencing
19. Development and verification of fingerprinting probes for Candida glabrata
20. Defenses against oral Candida carriage break down in the elderly
21. Most frequent scenario for recurrent Candida vaginitis is strain maintenance with "substrain shuffling": Demonstration by sequential DNA fingerprinting with probes Ca3, C1, and CARE2
22. Elucidating the origins of nosocomial infections with Candida albicans by DNA fingerprinting with the complex probe Ca3
23. Mechanisms of host defence against Candida species. I. Phagocytosis by monocytes and monocyte derived macrophages
24. Epidemiology of yeast colonization and oropharyngeal infection other than Candida albicans in patients with HIV infection
25. Production of beta-defensin antimicrobial peptides by the oral mucosa and salivary glands
26. Oral Candida dubliniensis as a clinically important species in HIV-seropositive patients in the United States
27. Random amplification of polymorphic DNA and microsatellite genotyping of pre- and posttreatment isolates of Candida spp. from human immunodeficiency virus-infected patients on different fluconazole regimens
28. The identification and tracking of Candida albicans isolates from oral lesions in HIV-seropositive individuals
29. Epidemiological and clinical aspects of mycoses in patients with AIDS-related pathologies
30. Predicting who will progress to AIDS
31. Oral candidiasis and immune status of HIV-infected patients
32. CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida species
33. Epidemiology of Candida infections in AIDS
34. Molecular typing of candida albicans isolated from oral lesions of HIV-infected individuals
35. Parity among the randomly amplified polymorphic DNA method, multilocus enzyme electrophoresis, and Southern blot hybridization with the moderately repetitive DNA probe Ca3 for fingerprinting Candida albicans
36. Variations in fluconazole susceptibility and DNA subtyping of multiple Candida albicans colonies from patients with AIDS and oral candidiasis suffering one or more episodes of infection
37. Telomeric and dispersed repeat sequences in Candida yeasts and their use in strain identification
38. Oral mycoses in HIV infection
39. Oral candidiasis and human immunodeficiency virus infection
40. Application of DNA typing methods to epidemiology and taxonomy of Candida species
41. Genetic similarity and maintenance of Candida albicans strains from a group of AIDS patients, demonstrated by DNA fingerprinting
42. Genetic similarity of Candida albicans strains from vaginitis patients and their partners
43. Computer-assisted methods for assessing strain relatedness in Candida albicans by fingerprinting with the moderately repetitive sequence Ca3
44. DNA fingerprinting of Candida albicans
45. The "ins and outs" of DNA fingerprinting the infectious fungi
46. Widespread geographic distribution of oral Candida dubliniensis strains in human immunodeficiency virus-infected individuals
47. Oral candida albicans in HIV infection
48. High levels of oral yeasts in early HIV-1 infection
49. Elevated phenotypic switching and drug resistance of Candida albicans from human immunodeficiency virus-positive individuals prior to first thrush episode